{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:30:15Z","timestamp":1789500615865,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic airway inflammation is recognized as an essential process in the pathogenesis of asthma. Cytokine profiles derived from immune and inflammation cells such as T-helper (Th) cells, eosinophilia and neutrophilia are not limited to the Th2 type in asthma. However, little is understood about associations between Th2-low inflammatory cytokine profiles and risk of asthma in adults. A case-control study of 910 adult asthma and 881 healthy controls was conducted. Inflammatory cytokines screening was undertaken by high-throughput protein microarray technology, and Th17-related inflammatory cytokines (IL17A, IL-9, adipsin and CCL11) were finally selected. Associations between these four cytokines and adult asthma risk were analyzed by multivariate logistic regression models. We observed that plasma IL-17A and IL-9 levels were significantly increased in asthmatics when compared with controls. However, the plasma expressions of adipsin and CCL11 in asthmatics were significantly lower than that in health controls. The adjusted ORs (95%CI) of association between IL-17A, IL-9, adipsin and CCL11 expressions and adult asthma were 3.08 (1.91, 4.97), 1.93 (1.41, 2.64), 10.02 (6.99, 14.37) and 3.29 (2.36, 4.59), respectively (all <jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&lt;\u20090.0001). Our results suggested that elevated IL-17A and IL-9 expressions and decreased levels of adipsin and CCL11 were positively associated with adult asthma.<\/jats:p>","DOI":"10.1038\/s41598-017-15570-8","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T10:42:30Z","timestamp":1510137750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Associations between Th17-related inflammatory cytokines and asthma in adults: A Case-Control Study"],"prefix":"10.1038","volume":"7","author":[{"given":"Ting","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"15570_CR1","first-page":"548","volume":"83","author":"J Bousquet","year":"2005","unstructured":"Bousquet, J., Bousquet, P. J., Godard, P. & Daures, J. P. The public health implications of asthma. Bull World Health Organ \n                           83, 548\u2013554 (2005).","journal-title":"Bull World Health Organ"},{"key":"15570_CR2","unstructured":"Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention for adults and children older than 5 years. [accessed on June 11, 2014]. [cited 2014 Jun 11]."},{"key":"15570_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJM199810223391703","volume":"339","author":"P Lange","year":"1998","unstructured":"Lange, P., Parner, J., Vestbo, J., Schnohr, P. & Jensen, G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med \n                           339, 1194\u20131200 (1998).","journal-title":"N Engl J Med"},{"key":"15570_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1164\/rccm.200402-230OC","volume":"171","author":"AL James","year":"2005","unstructured":"James, A. L. et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med \n                           171, 109\u2013114 (2005).","journal-title":"Am J Respir Crit Care Med"},{"key":"15570_CR5","unstructured":"Akinbami, L. J. et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001\u20132010. NCHS Data Brief, 1\u20138 (2012)."},{"key":"15570_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","volume":"382","author":"FD Martinez","year":"2013","unstructured":"Martinez, F. D. & Vercelli, D. Asthma. Lancet \n                           382, 1360\u20131372 (2013).","journal-title":"Lancet"},{"key":"15570_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel, S. E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med \n                           18, 716\u2013725 (2012).","journal-title":"Nat Med"},{"key":"15570_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar, P. et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med \n                           178, 218\u2013224 (2008).","journal-title":"Am J Respir Crit Care Med"},{"key":"15570_CR9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jaci.2010.03.003","volume":"125","author":"RH Dougherty","year":"2010","unstructured":"Dougherty, R. H. et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol \n                           125, 1046\u20131053 e1048 (2010).","journal-title":"J Allergy Clin Immunol"},{"key":"15570_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","volume":"118","author":"G Takayama","year":"2006","unstructured":"Takayama, G. et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol \n                           118, 98\u2013104 (2006).","journal-title":"J Allergy Clin Immunol"},{"key":"15570_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","volume":"180","author":"PG Woodruff","year":"2009","unstructured":"Woodruff, P. G. et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med \n                           180, 388\u2013395 (2009).","journal-title":"Am J Respir Crit Care Med"},{"key":"15570_CR12","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.12659\/MSM.896458","volume":"22","author":"AX Huang","year":"2016","unstructured":"Huang, A. X., Lu, L. W., Liu, W. J. & Huang, M. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-alpha Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome. Med Sci Monit \n                           22, 2800\u20132808 (2016).","journal-title":"Med Sci Monit"},{"key":"15570_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.coi.2013.08.002","volume":"25","author":"DC Newcomb","year":"2013","unstructured":"Newcomb, D. C. & Peebles, R. S. Jr. Th17-mediated inflammation in asthma. Curr Opin Immunol \n                           25, 755\u2013760 (2013).","journal-title":"Curr Opin Immunol"},{"key":"15570_CR14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1378\/chest.09-3058","volume":"138","author":"C Doe","year":"2010","unstructured":"Doe, C. et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest \n                           138, 1140\u20131147 (2010).","journal-title":"Chest"},{"key":"15570_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/rmed.2003.1507","volume":"97","author":"A Barczyk","year":"2003","unstructured":"Barczyk, A., Pierzchala, W. & Sozanska, E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med \n                           97, 726\u2013733 (2003).","journal-title":"Respir Med"},{"key":"15570_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.rmed.2010.02.018","volume":"104","author":"I Agache","year":"2010","unstructured":"Agache, I., Ciobanu, C., Agache, C. & Anghel, M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med \n                           104, 1131\u20131137 (2010).","journal-title":"Respir Med"},{"key":"15570_CR17","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1096\/fj.12-208033","volume":"26","author":"Y Chang","year":"2012","unstructured":"Chang, Y. et al. Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J \n                           26, 5152\u20135160 (2012).","journal-title":"FASEB J"},{"key":"15570_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2005.03.051","volume":"116","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto, K. et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol \n                           116, 550\u2013557 (2005).","journal-title":"J Allergy Clin Immunol"},{"key":"15570_CR19","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0812530106","volume":"106","author":"W Elyaman","year":"2009","unstructured":"Elyaman, W. et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3\u2009+\u2009natural regulatory T cells. Proc Natl Acad Sci USA \n                           106, 12885\u201312890 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"15570_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fimmu.2014.00440","volume":"5","author":"JA Mathews","year":"2014","unstructured":"Mathews, J. A., Wurmbrand, A. P., Ribeiro, L., Neto, F. L. & Shore, S. A. Induction of IL-17A Precedes Development of Airway Hyperresponsiveness during Diet-Induced Obesity and Correlates with Complement Factor D. Front Immunol \n                           5, 440 (2014).","journal-title":"Front Immunol"},{"key":"15570_CR21","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1084\/jem.20061401","volume":"203","author":"S Schnyder-Candrian","year":"2006","unstructured":"Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med \n                           203, 2715\u20132725 (2006).","journal-title":"J Exp Med"},{"key":"15570_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0091-6749(00)90185-4","volume":"105","author":"A Shimbara","year":"2000","unstructured":"Shimbara, A. et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol \n                           105, 108\u2013115 (2000).","journal-title":"J Allergy Clin Immunol"},{"key":"15570_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2466-11-14","volume":"11","author":"JM Parker","year":"2011","unstructured":"Parker, J. M. et al. Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm Med \n                           11, 14 (2011).","journal-title":"BMC Pulm Med"},{"key":"15570_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-9255-8-12","volume":"8","author":"S Leivo-Korpela","year":"2011","unstructured":"Leivo-Korpela, S. et al. Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma. J Inflamm (Lond) \n                           8, 12 (2011).","journal-title":"J Inflamm (Lond)"},{"key":"15570_CR25","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","volume":"185","author":"LA Zuniga","year":"2010","unstructured":"Zuniga, L. A. et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol \n                           185, 6947\u20136959 (2010).","journal-title":"J Immunol"},{"key":"15570_CR26","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1164\/ajrccm.164.10.2010096","volume":"164","author":"N Krug","year":"2001","unstructured":"Krug, N., Tschernig, T., Erpenbeck, V. J., Hohlfeld, J. M. & Kohl, J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med \n                           164, 1841\u20131843 (2001).","journal-title":"Am J Respir Crit Care Med"},{"key":"15570_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1164\/rccm.200306-855OC","volume":"169","author":"G Dent","year":"2004","unstructured":"Dent, G. et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Am J Respir Crit Care Med \n                           169, 1110\u20131117 (2004).","journal-title":"Am J Respir Crit Care Med"},{"key":"15570_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000072140","volume":"131","author":"SW Park","year":"2003","unstructured":"Park, S. W. et al. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol \n                           131, 283\u2013290 (2003).","journal-title":"Int Arch Allergy Immunol"},{"key":"15570_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1590\/S0100-879X2005000900010","volume":"38","author":"MB Daldegan","year":"2005","unstructured":"Daldegan, M. B., Teixeira, M. M. & Talvani, A. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. Braz J Med Biol Res \n                           38, 1359\u20131365 (2005).","journal-title":"Braz J Med Biol Res"},{"key":"15570_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.rmed.2004.01.005","volume":"98","author":"H Tateno","year":"2004","unstructured":"Tateno, H. et al. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir Med \n                           98, 782\u2013790 (2004).","journal-title":"Respir Med"},{"key":"15570_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3109\/02770903.2014.917659","volume":"51","author":"D Wu","year":"2014","unstructured":"Wu, D. et al. CCL11 as a potential diagnostic marker for asthma? J Asthma \n                           51, 847\u2013854 (2014).","journal-title":"J Asthma"},{"key":"15570_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall, J. C. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax \n                           54, 581\u2013586 (1999).","journal-title":"Thorax"},{"key":"15570_CR33","doi-asserted-by":"crossref","unstructured":"Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med \n                           152, 1107\u20131136 (1995).","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"15570_CR34","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA \n                           98, 5116\u20135121 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"15570_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11596-012-0023-9","volume":"32","author":"Y Liu","year":"2012","unstructured":"Liu, Y. & Chen, W. A. SAS macro for testing differences among three or more independent groups using Kruskal-Wallis and Nemenyi tests. J Huazhong Univ Sci Technolog Med Sci \n                           32, 130\u2013134 (2012).","journal-title":"J Huazhong Univ Sci Technolog Med Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15570-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:38:46Z","timestamp":1671802726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15570"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15570-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"assertion":[{"value":"30 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15502"}}